MYC and small cell lung carcinoma: However, in GEMMs incorporating oncogenic Myc activation, YAP1-positive tumors emerge in late-stage disease, with single-cell analyses indicating that these NE-low, YAP1-expressing tumors may originate from either SCLC-A or SCLC-N lineages [22,33].